| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 05/01/2001 | US6225347 For lowering blood pressure, inhibiting platelet aggregation, for luteolytic effect, healing ulcer, inhibiting gastric acid secretion, as cytoprotective agent |
| 04/26/2001 | WO2001028549A1 Anti-ischemic compounds |
| 04/26/2001 | WO2001028498A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387164A1 Anti-ischemic compounds |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | CN1292786A Process for producing simvastatin and/or its derivatives |
| 04/25/2001 | CN1292377A Synthesis preparation method of high-effective hemostatic notoginseng extract |
| 04/25/2001 | CN1292376A Synthesis method for preparing high-effective hemostatic notogiseng extract |
| 04/25/2001 | CN1064954C Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 04/24/2001 | US6221371 Pseudoceramides, and dermatologic external preparations containing the same |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | CA2165192C Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/19/2001 | WO2000050623A3 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives |
| 04/18/2001 | EP1092706A1 Process for the preparation of phenylalkanoic acid amides and intermediates therefor |
| 04/18/2001 | EP1092432A1 Anti-ischemic compounds |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | EP1091928A1 Novel acyl pseudodipeptides, preparation method and pharmaceutical compositions containing same |
| 04/18/2001 | EP1091924A1 Novel retinoids and use thereof |
| 04/18/2001 | EP0796240B1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 04/18/2001 | EP0736071B1 Derivatives of hydroxynaphthalenecarboxylic acid and azo colorants made therefrom |
| 04/17/2001 | US6218565 Method for producing N-(3-amino-4-fluoro-phenyl)-sulphonamides, N-(3-amino-4-fluoro-phenyl)-carboxylic acid amides and N-(3-amino-4-fluorophenyl) carbamates |
| 04/17/2001 | US6218432 Diamine alkylene diacetic or triacetic acid derivatives, preparation method, use in cosmetic and pharmaceutical compositions and compositions containing them |
| 04/17/2001 | CA2103044C Novel bi-aromatic compounds derived from a salicylic pattern, method of preparation and use in human and veterinary medicine and in cosmetics |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001025172A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | WO2001024786A1 Preventive or therapeutic drugs for diabetes |
| 04/12/2001 | CA2385715A1 A method for preparing and screening one or more compounds |
| 04/12/2001 | CA2372715A1 Preventive or therapeutic drugs for diabetes |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
| 04/11/2001 | EP1089988A1 Fluorophenyl resin compounds |
| 04/11/2001 | EP1089968A1 Thyroid hormone analogues and methods for their preparation |
| 04/11/2001 | EP0815071B1 Liposomogenic uv absorbers |
| 04/11/2001 | EP0809625B1 Anionic amphiphilic compounds with at least two hydrophilic and at least two hydrophobic groups based on dicarboxylic acid diamides |
| 04/11/2001 | CN1291215A Toning agent |
| 04/10/2001 | US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production |
| 04/10/2001 | US6214253 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 04/05/2001 | WO2001023347A1 Novel aromatic compounds |
| 04/05/2001 | WO2001023346A2 Process for phenylacetic acid derivatives |
| 04/04/2001 | EP1088481A2 Fungicides for the control of take-all disease of plants |
| 04/04/2001 | EP1087953A1 Nitrate salts of antihypertensive medicines |
| 04/03/2001 | US6211245 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021578A1 O-anisamide derivatives |
| 03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
| 03/29/2001 | WO2000059875A3 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
| 03/28/2001 | EP1086072A1 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof |
| 03/28/2001 | EP1085848A2 Inhibitors of transcription factor nf-kappa b |
| 03/28/2001 | EP1035772A4 Fungicidal compositions and methods, and compounds and methods for the preparation thereof |
| 03/28/2001 | EP0876330B1 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 03/27/2001 | US6207852 Smooth muscle spasmolytic agents, compositions and methods of use thereof |
| 03/22/2001 | WO2001019809A1 Tryptase inhibitors |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | CA2384763A1 Tryptase inhibitors |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1085009A1 Indan derivatives |
| 03/21/2001 | EP1084269A1 Novel peroxidase substrates and their use in catalyzed reporter deposition |
| 03/21/2001 | EP1084113A1 A process for the preparation of macrocyclic metalloprotease inhibitors |
| 03/21/2001 | EP1084103A1 New 3-aryl-2-hydroxypropionic acid derivative (i) |
| 03/21/2001 | EP1084102A1 New 3-aryl propionic acid derivatives and analogs |
| 03/21/2001 | EP1084098A1 Inhibitors of the anandamide transporter as analgesic agents |
| 03/21/2001 | EP0599886B1 Macromonomers having reactive end groups |
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/21/2001 | CN1063430C Ethanolamine derivatives |
| 03/20/2001 | US6204299 Foaming agents used to prepare closed cell polyurethane foams |
| 03/20/2001 | US6204287 Treating vision defects |
| 03/15/2001 | WO2001018092A1 Polyalkoxylated superamides optionally functionalised, use as emulsifiers |
| 03/15/2001 | WO2001018008A2 Decahydronaphthalene derivatives for molecular signal transduction |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 03/15/2001 | US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 03/15/2001 | DE19944892A1 Dekalinderivate zur molekularen Signaltransduktion Decalin derivatives of molecular signal transduction |
| 03/15/2001 | DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/15/2001 | DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/14/2001 | EP1082121A1 Hiv integrase inhibitors |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/13/2001 | US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/08/2001 | WO1999065449A8 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/07/2001 | EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1080065A1 A method of permanent fluorescent assay |
| 03/07/2001 | CN1286688A Method for preparation of citalopram |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/06/2001 | US6197798 Inhibitors of microsomal triglyceride transfer protein |
| 03/06/2001 | US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/01/2001 | WO2001014316A1 Substituted chiral allosteric hemoglobin modifiers |
| 03/01/2001 | WO2000058270A3 Hsv primase inhibitors |